PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
Shareholding Pattern

Aarti Drugs Limited

Promoter holding in Aarti Drugs Limited was 54.07% in Sep 2026, down 0.36 points from the previous quarter. Since Dec 2024 it has fallen 1.31 points.

By quarter

Promoters54.07%
Public45.93%
Promoter shares pledged (latest): 2.50% of promoter holding · see flags

Quarter by quarter

QuarterPromotersPublic
Sep '26 54.07%▼0.36 45.93%▲0.36
Jun '26 54.43%▼0.60 45.57%▲0.60
Mar '26 55.03%=0.00 44.97%=0.00
Dec '25 55.03%▲0.31 44.97%▼0.31
Sep '25 54.72%▼0.50 45.28%▲0.50
Jun '25 55.22%▼0.26 44.78%▲0.26
Mar '25 55.48%▲0.10 44.52%▼0.10
Dec '24 55.38%▼0.26 44.62%▲0.26

Trend

Compared with similar companies

Promoter holding in Aarti Drugs Limited is higher than 51% of companies in the Healthcare sector in India.

Similar-sized companies in the same sector, latest quarter on record.

Questions

What is Aarti Drugs Limited's promoter holding?

Promoters held 54.07% of Aarti Drugs Limited as of 30 Sep 2026, and the public held 45.93%.

Has Aarti Drugs Limited's promoter holding increased?

No, it fell by 0.36 percentage points in the quarter to Sep 2026.

Are any promoter shares of Aarti Drugs Limited pledged?

Yes, 2.50% of the promoter holding is pledged as loan collateral.

How has Aarti Drugs Limited's promoter holding changed over the years?

Over a longer period, promoter holding went from 60.12% in Sep 2021 to 54.07% in Sep 2026, down 6.05 points.

How does Aarti Drugs Limited's promoter holding compare with similar companies?

Promoter holding in Aarti Drugs Limited is higher than 51% of companies in the Healthcare sector in India. A higher or lower promoter holding is not good or bad by itself.

From the company's quarterly shareholding filings. "Public" includes institutions (foreign and domestic) and individual investors; a split by investor type is planned. ▲/▼ shows the change from the previous quarter, in percentage points. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.